Tevogen Inc.
TVGN· Nasdaq
TVGNTevogen Inc.
Filed Apr 29, 2024 · 10-K · 120 days after period end · 0001493152-24-016796
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|
| Net Income | -$3.63M | $2.61M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Apr 29, 2024 · 120 d after period end
